BRPI0410783A - aplicação de um polipeptìdeo - Google Patents

aplicação de um polipeptìdeo

Info

Publication number
BRPI0410783A
BRPI0410783A BRPI0410783-7A BRPI0410783A BRPI0410783A BR PI0410783 A BRPI0410783 A BR PI0410783A BR PI0410783 A BRPI0410783 A BR PI0410783A BR PI0410783 A BRPI0410783 A BR PI0410783A
Authority
BR
Brazil
Prior art keywords
polypeptide
application
biotinylated
modulate
enzyme
Prior art date
Application number
BRPI0410783-7A
Other languages
English (en)
Inventor
Norbert Tennagels
Aimo Kannt
Harald Thuering
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of BRPI0410783A publication Critical patent/BRPI0410783A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"APLICAçãO DE UM POLIPEPTìDEO". A presente invenção refere-se a uma aplicação de um polipeptídeo para a determinação da capacidade de uma enzima, um fragmento funcional ou derivado do mesmo, de modular o estado de fosforilação do polipeptídeo, caracterizado pelo fato de que o polipeptídeo é biotinilado.
BRPI0410783-7A 2003-05-22 2004-04-27 aplicação de um polipeptìdeo BRPI0410783A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10323081A DE10323081A1 (de) 2003-05-22 2003-05-22 Verwendung eines Polypeptides
PCT/EP2004/004428 WO2004104220A2 (de) 2003-05-22 2004-04-27 Verwendung eines biotinylierten polypeptides zur bestimmung der aktivität von protein-phosphorylierenden enzymen

Publications (1)

Publication Number Publication Date
BRPI0410783A true BRPI0410783A (pt) 2006-06-20

Family

ID=33441119

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410783-7A BRPI0410783A (pt) 2003-05-22 2004-04-27 aplicação de um polipeptìdeo

Country Status (14)

Country Link
US (1) US7732151B2 (pt)
EP (1) EP1627073A2 (pt)
JP (1) JP4740858B2 (pt)
KR (1) KR20060015290A (pt)
CN (1) CN100560732C (pt)
AU (1) AU2004241327B2 (pt)
BR (1) BRPI0410783A (pt)
CA (1) CA2526697A1 (pt)
DE (1) DE10323081A1 (pt)
IL (1) IL172008A (pt)
MX (1) MXPA05012521A (pt)
NO (1) NO20055990L (pt)
RU (1) RU2395813C2 (pt)
WO (1) WO2004104220A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2945263A1 (en) 2014-04-09 2015-10-15 Christopher Rudd Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
CN113933463B (zh) * 2021-10-14 2024-04-02 丽江英煌集生物工程有限公司 一种玛咖多肽活性的快速分检装置及分检方法
CN115851602A (zh) * 2022-10-10 2023-03-28 安阳师范学院 一种kras点突变的肿瘤细胞及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711341A4 (en) * 1993-07-29 2001-12-19 Cor Therapeutics Inc RECEPTION FUNCTION TESTS
US5763198A (en) * 1994-07-22 1998-06-09 Sugen, Inc. Screening assays for compounds
EP0873142A4 (en) * 1995-06-07 2001-08-08 Sugen Inc CONNECTION TESTING TESTS
US5759787A (en) * 1996-08-26 1998-06-02 Tularik Inc. Kinase assay
ATE296446T1 (de) * 1997-01-15 2005-06-15 Telik Inc Modulatoren von insulinrezeptor-aktivität
DK1036192T3 (da) * 1997-12-05 2003-06-10 Upjohn Co Fluorescensbaserede screeningsanalyser med høj hastighedforproteinkinaser og phosphataser
DE60045586D1 (de) * 1999-06-09 2011-03-10 Molecular Devices Inc Testverfahren zur messung der phosphorylierung

Also Published As

Publication number Publication date
WO2004104220A2 (de) 2004-12-02
WO2004104220A3 (de) 2005-06-09
MXPA05012521A (es) 2006-05-25
IL172008A (en) 2011-12-29
US7732151B2 (en) 2010-06-08
HK1092840A1 (zh) 2007-02-16
RU2395813C2 (ru) 2010-07-27
CN100560732C (zh) 2009-11-18
NO20055990L (no) 2006-02-14
JP2007512802A (ja) 2007-05-24
KR20060015290A (ko) 2006-02-16
JP4740858B2 (ja) 2011-08-03
DE10323081A1 (de) 2004-12-16
CA2526697A1 (en) 2004-12-02
US20080020399A1 (en) 2008-01-24
CN1795273A (zh) 2006-06-28
RU2005140091A (ru) 2006-05-10
AU2004241327B2 (en) 2010-03-25
AU2004241327A1 (en) 2004-12-02
EP1627073A2 (de) 2006-02-22

Similar Documents

Publication Publication Date Title
BR0209312A (pt) Composição alimentìcia de isolado de proteìna de canola
BR0310099A (pt) método para tratar dislipidemia ou uma doença associada com a dislipidemia
BR0310092A (pt) Combinação de compostos orgânicos
BR0317392A (pt) Formulação não-higroscópica incluindo uma droga higroscópica
BRPI0519349A8 (pt) Prevenção de formação e/ou estabilização de trombos
BRPI0407922A (pt) derivados de isoquinolina e métodos de uso destes
BR0206381A (pt) Derivados do ácido fumárico como inibidor de nf-kappab
SI1536827T1 (sl) Uporaba protein-kinaze n beta
ECSP067043A (es) Derivados de pirrolotriazina útiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogénesis
ATE543521T1 (de) Calciumphosphat-zement
BRPI0618451A2 (pt) derivados de piridopirazina, seu uso, composição farmacêutica e estojo
BRPI0407454A (pt) Pirazóis e métodos de preparar e usar os mesmos
BRPI0609121B8 (pt) 1h-benzimidazol-4-carboxamidas substituídas com um carbono quaternário na posição 2
BRPI0418031A (pt) inibidores de quinase fosfonato-substituìdos
BR0208142A (pt) Combinações compreendendo um agente antidiarréico e epotilona ou derivado de epotilona
WO2002030353A3 (en) NF-λB INHIBITORS
DK0450991T3 (da) Anvendelse af phospholipider til behandling af luftvejsobstruktionssygdomme
ECSP077270A (es) Ácidos de tiazolo - naftilo
HUP0402506A2 (hu) FBPáz inhibitorok és inzulinérzékenység-fokozók kombinációja diabétesz kezelésére
PA8562901A1 (es) Inhibidores de la fosfatasa
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
BRPI0509903A (pt) uso de compostos peptìdicos para profilaxia e tratamento da cefaléia crÈnica
BRPI0514549A (pt) ácidos de pirrol-naftila como inibidores de pai-1
BR0213181A (pt) Combinações de inibidor de cox-2
BR0209128A (pt) Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos

Legal Events

Date Code Title Description
B10A Cessation: cessation confirmed

Free format text: HOMOLOGADA A DESISTENCIA DO PEDIDO, SOLICITADA ATRAVES DA PETICAO NO 020120004053/RJ DE16/01/2012.